School of Allied Health Sciences, Griffith University, Gold Coast, QLD, Australia; Griffith Centre of Biomedical and Rehabilitation Engineering, Menzies Health Institute Queensland, Advanced Design and Prototyping Technologies Institute (ADAPT), Griffith University, Gold Coast, QLD, Australia.
Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Mass General Brigham, and Harvard Medical School, Boston, MA, United States.
Exp Neurol. 2021 May;339:113612. doi: 10.1016/j.expneurol.2021.113612. Epub 2021 Jan 14.
This paper is an interdisciplinary narrative review of efficacious non-invasive therapies that are increasingly used to restore function in people with chronic spinal cord injuries (SCI). First presented are the secondary injury cascade set in motion by the primary lesion and highlights in therapeutic development for mitigating the acute pathophysiologic process. Then summarized are current pharmacological strategies for modulation of noradrenergic, serotonergic, and dopaminergic neurotransmission to enhance recovery in bench and clinical studies of subacute and chronic SCI. Last examined is how neuromechanical devices (i.e., electrical stimulation, robotic assistance, brain-computer interface, and augmented sensory feedback) could be comprehensively engineered to engage efferent and afferent motosensory pathways to induce neuroplasticity-based neural pattern generation. Emerging evidence shows that computational models of the human neuromusculoskeletal system (i.e., human digital twins) can serve as functionalized anchors to integrate different neuromechanical and pharmacological interventions into a single multimodal prothesis. The system, if appropriately built, may cybernetically optimize treatment outcomes via coordination of heterogeneous biosensory, system output, and control signals. Overall, these rehabilitation protocols involved neuromodulation to evoke beneficial adaptive changes within spared supraspinal, intracord, and peripheral neuromuscular circuits to elicit neurological improvement. Therefore, qualitatively advancing the theoretical understanding of spinal cord neurobiology and neuromechanics is pivotal to designing new ways to reinstate locomotion after SCI. Future research efforts should concentrate on personalizing combination therapies consisting of pharmacological adjuncts, targeted neurobiological and neuromuscular repairs, and brain-computer interfaces, which follow multimodal neuromechanical principles.
本文是一篇跨学科的叙事性综述,探讨了越来越多用于恢复慢性脊髓损伤(SCI)患者功能的非侵入性有效疗法。首先介绍的是原发性损伤引发的继发性损伤级联反应,并重点介绍了减轻急性病理生理过程的治疗开发进展。然后总结了目前用于调节去甲肾上腺素能、5-羟色胺能和多巴胺能神经传递以增强亚急性和慢性 SCI bench 和临床研究中恢复的药理学策略。最后研究了如何综合设计神经机械装置(即电刺激、机器人辅助、脑机接口和增强感觉反馈),以激活传出和传入运动感觉通路,从而诱导基于神经可塑性的神经模式生成。新出现的证据表明,人类神经肌肉骨骼系统的计算模型(即人类数字双胞胎)可以作为功能化的锚点,将不同的神经机械和药理学干预整合到单个多模态假体中。如果构建得当,该系统可以通过协调异构生物感觉、系统输出和控制信号,对治疗结果进行神经控制优化。总的来说,这些康复方案涉及神经调节,以引起未受损的脊髓上、脊髓内和周围神经肌肉回路中的有益适应性变化,从而产生神经学改善。因此,深入了解脊髓神经生物学和神经力学的理论对于设计 SCI 后恢复运动的新方法至关重要。未来的研究工作应集中于个性化组合疗法,包括药理学辅助、靶向神经生物学和神经肌肉修复以及脑机接口,这些疗法遵循多模态神经机械原则。